Scottish most cancers therapies agency receives bumper £9m funding
SCOTTISH most cancers therapeutics growth specialist, Cumulus Oncology, has secured a bumper £9m funding package deal. The Edinburgh-based enterprise creates spin-out firms concerned within the growth of groundbreaking new most cancers therapies. Cumulus will use the funding, which incorporates £6m from the Scottish Nationwide Funding Financial institution, to…